Shares of Global X Interest Rate Hedge ETF (NYSEARCA:RATE – Get Rating) fell 0.3% during mid-day trading on Tuesday . The stock traded as low as $26.52 and last traded at $26.52. 1,251 shares changed hands during mid-day trading, an increase of 142% from the average session volume of 517 shares. The stock had previously closed at $26.60.
Global X Interest Rate Hedge ETF Price Performance
The firm's fifty day simple moving average is $25.32.
See Also
- Get a free copy of the StockNews.com research report on Global X Interest Rate Hedge ETF (RATE)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets "Powelled": S&P 500 Confirms Resistance
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Rivian Plummets, But Is This 2023's Greatest Buying Opportunity?
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for Global X Interest Rate Hedge ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Interest Rate Hedge ETF and related companies with MarketBeat.com's FREE daily email newsletter.
周二午盘,Global X利率对冲ETF(NYSEARCA:Rate-Get Rating)的股价下跌0.3%。该股一度跌至26.52美元,最后报26.52美元。午盘交易中有1,251股易手,较517股的平均日成交量增加142%。该股此前收盘价为26.60美元。
Global X利率对冲ETF价格表现
该公司的50日简单移动均线为25.32美元。
另请参阅
- 免费获取StockNews.com关于Global X利率对冲ETF(利率)的研究报告
- 低调的Azul SA公司乘着强劲的旅行需求起飞
- 市场受挫:标普500指数确认阻力
- Ulta内部人士持股:卖出-买入
- Rivian应运而生,但这是2023年最大的收购机会吗?
- 潜在收益将Ambrx Biophma评为中等买入
接受Global X利率对冲ETF日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收关于Global X利率对冲ETF和相关公司的最新新闻和分析师评级的每日摘要。